Bronchopulmonary Aspergillosis Invasive and Antifungal Treatment Response.

2013, Number 105

Rev Enfer Infec Pediatr 2013; 26.27 (105)

Vázquez TÓ, Félix BGE, Campos RT

Language: Spanish
References: 3
Page: 327-329
PDF size: 563.86 Kb.

Text Extraction

No abstract

REFERENCES

Raad II, Hanna HA, Boktour M, et al. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia. 2008; (22): 496-503.
Schwartz S, Ruhnke M, Ribaud P et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 2005; (106): 2641–5.
Patterson T, Boucher H, Herbrecht R, et al. Strategy of Following Voriconazole versus Amphotericin B. Therapy with Other Licensed Antifungal Therapy for Primary Treatment of Invasive Aspergillosis: Impact of Other Therapies on Outcome. Clinical Infectious Disease. 2005; (41): 1488-52.